Genomics of Drug Sensitivity in Cancer Linifanib
Synonyms ABT-869, ABT 869
Targets VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT
Target pathway RTK signaling
PubCHEM ID 11485656
Jsmol
Download molecule 11485656
PUBCHEM IUPAC INCHI InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)
Smiles FC4(=C(NC(=O)NC3(=CC=C(C2(=C1(C(=NNC1=CC=C2)N)))C=C3))C=C(C)C=C4)
Cluster number 71
calculated LogS -7,063
Molecular weight 375,406
calculated LogP 3,7895
H-Acceptors 6
H-Donors 4
Ro5 violations 0
Druglikeness 0,30235
DrugScore 7,61029292682387E-02
Mutagenic high
Tumorigenic high
Reproductive Effective none
Irritant high
Fish Toxicity High FHMT
Fish Toxicity2 1,5103
Rat Acute Toxicity 2,6035
Acute Oral Toxicity III
Caco-2 Permeability Caco2-
Caco-2 Permeability2 0,6837
P-glycoprotein Substrate Non-substrate
P-glycoprotein Inhibitor Non-inhibitor
P-glycoprotein Inhibitor2 Non-inhibitor
Human Ether-a-go-go-Related Gene Inhibition Weak inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Non-inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,5057
AMES Toxicity Non AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Non-substrate
CYP450 3A4 Inhibitor Inhibitor
CYP450 2C19 Inhibitor Inhibitor
CYP450 2C9 Inhibitor Non-inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB+
CYP Inhibitory Promiscuity High CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Non-inhibitor
Subcellular localization Mitochondria
Human Intestinal Absorption HIA+
Aqueous solubility -3,3623
Information useful only for research purposes.